ATG Fund II LLC 13D/13G Filings for Forte Biosciences, Inc. (FBRX)

ATG Fund II LLC 13D and 13G filings for Forte Biosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-08-10
09:20 am
Unchanged		 2023-08-18 13D Forte Biosciences, Inc.
FBRX		 ATG Fund II LLC 58,480
4.000%		 0
(Unchanged)		 Filing
2022-08-04
4:30 pm
Purchase		 2022-07-25 13D Forte Biosciences, Inc.
FBRX		 ATG Fund II LLC 58,480
9.900%		 58,480increase
(New Position)		 Filing